NBA Hall-of-Famer Dominique Wilkins will be at the SOMC Friends Center to help “Slam Dunk Diabetes” at 5:00pm on April 8.
Wilkins, a nine-time NBA All Star and two-time Slam Dunk Champion, is best known for his years as a professional basketball player with the Atlanta Hawks. He is also a diabetic, however, and will be sharing his personal experiences with diabetes during the event.
There will be a brief question and answer session following the event.
“We’re very excited to welcome Dominique Wilkins to Portsmouth,” Friends Center Manager Jennifer Schackart said. “It’s not often that you get to see a member of the NBA Hall of Fame, and we hope that the community will take advantage of this rare opportunity.”
Dominique Wilkins played college basketball at the University of Georgia and entered the NBA as a first-round draft pick in 1982. He was key to the Atlanta Hawks winning more than 50 games in four straight seasons. In 1986, Wilkins averaged 30.3 points per game and won the NBA scoring title.
In 1994, Wilkins became one of only three Hawks to have his jersey retired. He would go on to play for the Los Angeles Clippers, the Boston Celtics, the San Antonio Spurs and the Orlando Magic.
He was known for his acrobatic slam-dunks, which earned him the nickname “The Human Highlight Film.” He joined the Georgia Sports Hall of Fame in 2004, the Atlanta Sports Hall of Fame in 2005 and the Naismith Memorial Basketball Hall of Fame in 2006.
Wilkins first learned that he had type 2 diabetes in 2000.
“I went through denial for about a week,” Wilkins said. “I thought, ‘I can’t have diabetes. I’m in great shape.’”
Since then, Wilkins has adjusted to his diabetes by making changes that have allowed him to feel better and enjoy his life. He now serves as the Vice President of Basketball for the Atlanta Hawks and has become a Corporate Ambassador of Novo Nordisk, Inc., the world’s leading diabetes care company, to help change the way people think about living with diabetes.
About Novo Nordisk
Novo Nordisk is a global healthcare company with nearly a century of innovation and achievement in diabetes care. Always keeping our focus on individual needs and desires, Novo Nordisk has made major breakthroughs in insulin therapy. Since we first marketed insulin in 1923, we have led the industry with such innovations as NPH, the Lente formulations, the first commercially available human insulin, and the first premixed human insulin.
We strive to provide optimal care and to put patient needs at the center of everything we do. To learn more about Novo Nordisk and our products, visit NovoNordisk-US.com.